The Global Immuno-Oncology Assays Market Report is a compilation of comprehensive research studies of various aspects of the Immuno-Oncology Assays Market. With accurate data and highly authentic information, a brilliant attempt is made to paint a true, transparent picture of the current and future situations of the global Immuno-Oncology Assays market. Market participants can use this powerful tool when creating effective business plans or making major changes to their strategies. The report discusses the growth of the global as well as regional markets. It also throws light on high-growth segments of the global Immuno-Oncology Assays market and how they will evolve in the years to come.
Request a PDF sample copy of this report at @ https://www.absolutemarketsinsights.com/request_sample.php?id=806
Global immuno-oncology assays market was valued at US$ 3172.40 million in 2022 and is expected to reach US$ 9517.40 million by 2030, growing at a CAGR of 13.1% over the forecast period.. Agilent, BioAgilytix, Charles River Laboratories, Creative Biolabs, Eurofins DiscoverX Products, Explicyte Immuno-Oncology, Illumina, Inc., Svar Life Science, Thermo Fisher Scientific and other market participants.
Immuno-oncology assays are a next-generation sequencing technology that provides automated immune and tumour cell dynamic measurements in real time. Biological processes driving the immune response to cancer can be studied with the aid of this assays. This assay helps preserve cell health and morphology and provides continuous analysis in real time. Factors such as the growing acceptance of targeted therapy over conventional therapy and increasing demand for mAbs are primarily driving the growth of this sector. Immuno-oncology research requires the use of multiple immunology tests that are used to monitor the relationship between immune cells and cancer cells. There is a tremendous opportunity for the human body’s immune system to kill tumour cells, causing no toxicity to normal cells. In addition, the immune system also has the potential to prevent cancer recurrence.
Amongst diseases, cancer will boost the growth of the market over the forecast period. In addition, increasing targeted therapy adoption is boosting the growth of the market. In order to measure the concentration of therapeutic antibodies, anti-drug antibodies and soluble protein biomarkers immune-oncology assays are used. The market growth of assays increases as the popularity of targeted therapy increases.
The key factor in increasing market growth is increasing healthcare expenditure, increasing cancer prevalence, increasing patient preference for immunotherapies and immunodiagnostics due to side effects of radiation and chemotherapy and technological advances in the immune-oncology assay. However, the rising unfavourable regulatory and reimbursement scenario and the increased amount of capital investments are the main factors that will hinder market growth and will further challenge the growth of the market for immuno-oncology assays in the forecast period. The production of immuno-oncology assays has several challenges and requires specialist teams and experienced investigators. High costs and time required for manufacturing are also associated with the production of immuno-oncology assays. These variables are expected to hamper market growth over the forecast period.
During the forecast period, new product launches are expected to propel the growth of the immuno-oncology market. Roche Diagnostics, for example, launched the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay in April 2019 to identify the biomarker of human epidermal growth factor receptor 2 (HER2) in breast and gastric cancers. In addition, key market players are focused on the launch of new immune-oncology assays, which are expected to drive the growth of the market for immune oncology assays. The growth of the global immuno-oncology assay market is driven by increased research and development activities for cancer treatment and the increase in the use of personalized medicines across the globe. Due to the reduction in test rates and the delay in cancer diagnosis, demand for immuno-oncology assays is expected to decrease during the Covid-19 pandemic. The repurposing of laboratory resources to provide Covid-19 research has impacted the capacity of laboratories involved in oncology testing, resulting in a decrease in the testing rate.
Purchase the latest in-depth Market Report @ https://www.absolutemarketsinsights.com/checkout?id=806
Immuno-oncology Assays Market:
- By Component
- Consumables
- Cytotoxicity Assays
- MOA-Reflective Functional Assays for Co-Stimulatory and Inhibitory Checkpoint Receptors
- Functional Assays
- Custom
- Others
- Software Platform
- Immunoassay
- PCR
- NGS
- Flow Cytometry
- Others
- Consumables
- By Technology
- 2D
- 3D
- By Cell Types
- Natural Killer Cells
- Macrophages
- Dendritic Cells
- Neutrophils
- Fibroblasts
- Others
- By Application
- Screen and Develop Antibodies
- Small Molecules
- Cellular Therapies (Chimeric Antigen Receptor T Cells (CAR-T)
- ADCC
- ADCP
- T Cell Redirection
- Adoptive T Cell Therapy
- Others
- By Targets
- PD-1
- SIRPα
- CTLA4
- OX40
- ICOS
- Others
- By Indication
- Lung Cancer
- Colorectal Cancer
- Melanoma
- Bladder Cancer
- Other Cancers
- By Usage
- Research Solutions
- Tumor Microenvironment and Immune Composition
- Tumor Mutational Burden and Neoantigens
- Cancer Microbiome Research
- Immunotherapy Research Publications
- Others
- Others
- Research Solutions
- By Geography
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Besides target market information, Absolute Markets Insights also provides information about your competitor, your customers, products etc. A few techniques we use are:
- Customer analysis
- Competitor analysis
- Risk analysis
- Product research
- Advertising research
- E-mail survey and many more…
- Market Research Methodology
We define the research problem: The step defining the research problem exists of two main steps:
- Formulating the problem
- Establishing research objectives
- Selecting and Establishing Research Design
The step selecting and establishing research design consists of three main steps:
- Select the research design
- Identify information types and sources
- Determine and design research instrument
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com
